Dallas, TX, United States of America

Joan Elizabeth Smallshaw

This inventor holds 6 USPTO granted patents and 1 EPO patent. Top assignee: The University of Texas System. Active years: 2003-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joan Elizabeth Smallshaw. Retrieved from https://idiyas.com/inventor/joan-elizabeth-smallshaw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0


Average Co-Inventor Count = 4.0

ph-index = 4

Forward Citations = 36(Granted Patents)


Location History:

  • Irving, TX (US) (2005 - 2008)
  • Dallas, TX (US) (2003 - 2012)

Company Filing History:


Years Active: 2003-2012

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Innovations by Joan Elizabeth Smallshaw

Introduction

Joan Elizabeth Smallshaw is a prominent inventor based in Dallas, TX (US). She has made significant contributions to the field of immunology and toxicology, holding a total of six patents. Her work focuses on developing innovative methods to create safer vaccines and immunotoxins.

Latest Patents

One of her latest patents is titled "Ricin A chain mutants lacking enzymatic activity as vaccines to protect against aerosolized ricin." This invention provides methods to produce toxoid vaccines, such as ricin A chain vaccines, with a reduced ability to promote vascular leak syndrome (VLS) and catalytic toxicity associated with various proteinaceous toxins. The invention also includes toxoids that have been mutated to lack amino acid sequences which induce VLS and toxic catalytic activity. Another significant patent is "Compositions and methods for modifying toxic effects of proteinaceous compounds." This invention outlines methods to produce immunotoxins and cytokines with a reduced ability to promote VLS. It also discloses peptides that inhibit the induction of VLS by immunotoxins and cytokines.

Career Highlights

Joan has dedicated her career to advancing the understanding of proteinaceous toxins and their effects on human health. Her innovative approaches have led to the development of safer therapeutic options for patients. She is affiliated with the University of Texas System, where she continues her research and development efforts.

Collaborations

Joan has collaborated with notable scientists in her field, including Ellen S Vitetta and Victor F Ghetie. These collaborations have further enhanced her research and contributed to the advancement of immunological studies.

Conclusion

Joan Elizabeth Smallshaw is a trailblazer in the field of immunology, with her patents reflecting her commitment to improving public health through innovative research. Her work continues to inspire future advancements in vaccine development and toxicology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…